Probing the link between gross profitability and R&D spending

Health Affairs

Volumn 20, Issue 5, 2001, Pages 221-222

  Lichtenberg, Frank R ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COST BENEFIT ANALYSIS; DRUG INDUSTRY; DRUG SCREENING; ECONOMIC ASPECT; ECONOMICS; HUMAN; NOTE; RESEARCH; UNITED STATES;

COST-BENEFIT ANALYSIS; DRUG EVALUATION; DRUG INDUSTRY; ECONOMIC COMPETITION; HUMANS; RESEARCH; UNITED STATES;

EID: 0035459318     PISSN: 02782715     EISSN: None     Source Type: Journal    
DOI: 10.1377/hlthaff.20.5.221     Document Type: Article

References (1)

1. F.R. Lichtenberg, "Public Policy and Innovation in the U.S. Pharmaceutical Industry," in Entrepreneurship and Public Policy, ed. D. Holtz-Eakin (Boston: MIT Press, forthcoming).